P2 receptor-mediated inhibition of adenylyl cyclase in PC12 cells

European Journal of Pharmacology

Volumn 348, Issue 1, 1998, Pages 71-76

  Murayama, Toshihiko ^a   Yakushi, Yoshihiro ^a   Watanabe, Asako ^a   Nomura, Yasuyuki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

ATP; cAMP; P2Y receptor; PC12 cell

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; ADENOSINE 5' O (2 THIODIPHOSPHATE); ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ADENYLATE CYCLASE; CIBACRON BLUE F3GA; CYCLIC AMP; FORSKOLIN; PERTUSSIS TOXIN; PURINE P2 RECEPTOR; RECEPTOR SUBTYPE; ROLIPRAM; SURAMIN; URIDINE TRIPHOSPHATE;

ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CATECHOLAMINE RELEASE; CELL STRAIN; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; ADENYLATE CYCLASE TOXIN; ANIMALS; ANTINEOPLASTIC AGENTS; CALCIUM; CYCLIC AMP; FORSKOLIN; PC12 CELLS; PERTUSSIS TOXIN; PROTEIN KINASE C; RATS; RECEPTORS, PURINERGIC P2; SURAMIN; VIRULENCE FACTORS, BORDETELLA;

EID: 0032078708     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00130-7     Document Type: Article

References (38)

1. Akbar G.K.M., Dasari V.R., Webb T.E., Ayyanathan K., Pillarisetti K., Sandhu A.K., Athwal R.S., Daniel J.L., Ashby B., Barnard E.A., Kunapuli S.P. Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells. J. Biol. Chem. 271:1996;18363-18367.
2. 2Y-purinergic receptor that inhibits adenylyl cyclase. J. Pharmacol. Exp. Ther. 267:1993;1140-1146.
3. Brake A.J., Wagenbach W.J., Julius D. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature. 371:1994;519-523.
4. 2 nucleotide receptor. J. Biol. Chem. 270:1995;26152-26158.
5. Communi D., Pirotton S., Parmentier M., Boeynaems J.-M. Cloning and functional expression of a human uridine nucleotide receptor. J. Biol. Chem. 270:1995;30849-30850.
6. Communi D., Govaerts C., Parmentier M., Boeynaems J.-M. Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J. Biol. Chem. 272:1997;31969-31973.
7. Dalziel H.H., Westfall D.P. Receptors for adenine nucleotides and nucleosides: subclassification, distribution and molecular characterization. Pharmacol. Rev. 46:1994;449-466.
8. Dorflinger L.J., Albert P.J., Williams A.T., Behrman H.R. Calcium is an inhibitor of leuteinizing hormone-sensitive adenylate cyclase in the luteal cell. Endocrinology. 114:1984;1208-1215.
9. El-Moatassim C., Dornand J., Mani J.-C. Extracellular ATP and cell signaling. Biochim. Biophys. Acta. 1134:1992;31-45.
10. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:1994;143-156.
11. Gordon J.L. Extracellular ATP: effects, sources and fate. Biochem. J. 233:1986;309-319.
12. 2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br. J. Pharmacol. 99:1990;617-621.
13. Inoue K., Nakazawa K., Ohara-Imaizumi M., Obana T., Fujimori K., Takanaka A. Selective and competitive antagonism by suramin of ATP-stimulated catecholamine-secretion from PC12 phaeochromocytoma cells. Br. J. Pharmacol. 102:1991;581-584.
14. m, rolipram-sensitive cAMP phosphodiesterase. J. Biol. Chem. 267:1992;18929-18939.
15. Keppens S., Vandekerckhove A., Wulf H.D. Extracellular ATP and UTP exert similar effects on rat isolated hepatocytes. Br. J. Pharmacol. 105:1992;475-479.
16. Majid M.A., Okajima F., Kondo Y. Characterization of ATP receptor which mediates norepinephrine release in PC12 cells. Biochim. Biophys. Acta. 1136:1992;283-289.
17. 2+ system through a receptor different from the 53-kDa ATP receptor in PC12 cells. Biochem. Biophys. Res. Commun. 195:1993;415-421.
18. 2+ and cAMP levels by protein kinase C. Mol. Pharmacol. 44:1993;1185-1191.
19. Murayama T., Ui M. Loss of the inhibitory function of the guanine nucleotide regulatory component of adenylate cyclase due to its ADP ribosylation by islet-activating protein, pertussis toxin, in adipocyte membranes. J. Biol. Chem. 258:1983;3319-3326.
20. Murayama T., Ui M. Receptor-mediated inhibition of adenylate cyclase and stimulation of arachidonic acid release in 3T3 fibroblasts. J. Biol. Chem. 260:1985;7226-7233.
21. Murayama T., Ui M. Phosphatidic acid may stimulate membrane receptors mediating adenylate cyclase inhibition and phospholipid breakdown in 3T3 fibroblasts. J. Biol. Chem. 262:1987;5522-5529.
22. Murayama T., Oda H., Watanabe A., Nomura Y. ATP receptor-mediated increase of Ca ionophore-stimulated arachidonic acid release from PC12 pheochromocytoma cells. Jpn. J. Pharmacol. 69:1995;43-51.
23. Murayama T., Oda H., Nomura Y. Pertussis toxin-insensitive effects of mastoparan, a wasp venom peptide, in PC12 cells. J. Cell. Physiol. 169:1996;448-454.
24. Nakazawa K., Fujimori K., Takanaka A., Inoue K. Reversible and selective antagonism by suramin of ATP-activated inward current in PC12 phaeochromocytoma cells. Br. J. Pharmacol. 101:1990;224-226.
25. 3H] noradrenaline from PC12 cells J. Biochem. 118:1995;325-331.
26. i elevation or noradrenaline release in PC12 cells. Arch. Biochem. Biophys. 332:1996;1-7.
27. Oda H., Murayama T., Nomura Y. Inhibition of protein kinase C-dependent noradrenaline release by wortmannin in PC12 cells. Arch. Biochem. Biophys. 337:1997;96-102.
28. 2-Purinergic receptors are coupled to two signal transduction systems leading to inhibition of cAMP generation and to production of inositol trisphosphate in rat hepatocytes. J. Biol. Chem. 262:1987;13483-13490.
29. 2-purinergic stimulation of phosphoinositide turnover and arachidonate release in FRTL-5 thyroid cells. J. Biol. Chem. 264:1989;13029-13037.
30. Pianet I., Merle M., Labouesse J. ADP and, indirectly, ATP are potent inhibitors of cAMP production in intact isoproterenol-stimulated C6 glioma cells. Biochem. Biophys. Res. Commun. 163:1989;1150-1157.
31. Tang W.-J., Gilman A.G. Adenylyl cyclases. Cell. 70:1992;869-872.
32. Taussing R., Gilman A.G. Mammalian membrane-bound adenylyl cyclases. J. Biol. Chem. 270:1995;1-4.
33. Ui M. Islet-activating protein, pertussis toxin: a probe for functions of the inhibitory guanine nucleotide regulatory component of adenylate cyclase. Trends Pharmacol. Sci. 5:1934;277-279.
34. Valeins H., Merle M., Labouesse J. Pre-steady state study of β-adrenergic and purinergic receptor interaction in C6 cell membranes: undelayed balance between positive and negative coupling to adenylyl cyclase. Mol. Pharmacol. 42:1992;1033-1041.
35. 2X receptor for extracellular ATP. Nature. 371:1994;516-519.
36. Webb T.E., Simon J., Krishek B.J., Bateson A.N., Smart T.G., King B.F., Burnstock G., Barnard E.A. Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett. 324:1993;219-225.
37. 5. Biochem. Biophys. Res. Commun. 219:1996;105-110.
38. 2 puronoceptor-mediated stimulation of adenylyl cyclase in PC12 cells. Eur. J. Pharmacol. 314:1996;243-248.